This on-demand webinar from DNA Script provides an overview of enzymatic DNA synthesis (EDS), the core technology behind the Syntax benchtop enzymatic DNA printer, which the Pasteur Institute has leveraged for a variety of applications, including rRNA depletion, COVID-19 research, and mutagenesis studies.
As an example of how oligos on demand can accelerate innovation, the Pasteur Institute's Colin Clairet describes his current project involving mutant construction of the rising fungal pathogen Candida glabrata using Syntax oligos.
Offered Free by: DNA Script
See All Resources from: DNA Script
This download should complete shortly. If the resource doesn't automatically download, please, click here.